Pharmaceutical Market Forecast Revised

We have revised downwards our forecast for pharmaceutical expenditure in the UK, following BMI's Country Risk team's amendment of medium-term economic growth forecasts on the back of the UK government's plan for a major structural overhaul of public finances, coupled with the weakness of domestic spending and investment data.

To read the full article, please choose one of the following options: